Table 4.
Model/Condition/Disease | Treatment (Doses and Duration) | Increased Bacteria | Decreased Bacteria | Other Effects | Reference |
---|---|---|---|---|---|
In vitro (after simulated gastrointestinal digestion and 24-h-fermentation) on fermentation broth of human feces | HEPs 1 (HEP-30, HEP-50, and HEP-70) | SCFA 2-producing bacteria: Lactobacillus, Faecalibacterium, Bifidobacterium, Blautia, Butyricicoccus | Pathogenic bacteria: Klebsiella, Escherichia-Shigella, Enterobacter | - | [110] |
In vitro (static batch culture 24 h fermentations and fecal inocula from elderly donors) | HEBS 3 and HEOLRP 4 | - | - | Increasing propionate and butyrate levels. | [113] |
Healthy adults (30.0 ± 4.9 years old) | 1 g of H. erinaceus powder three times a day (7 days of washout) | SCFA-producing bacteria: Eubacterium rectale, Faecalibacterium prausnitzii, Kineothrix alysoides, Gemmiger formicilis, Fusicatenibacter saccharivorans | Pathobionts: Bacteroides caccae, Streptococcus thermophilus, Romboutsia timonensis | Increasing in GM 5 alpha diversity. GM changes related to blood ALP 6, LDL 7, UA 8, and CREA 9. | [112] |
Aged dogs | H. erinaceus 0.8 g per bw 10 with daily diets for 16 weeks | Bacteroidetes (order Bacteroidales) | Firmicutes: Streptococcus, Tyzzerella, Campylobacteraceae (genus Campylobacter) | - | [114] |
Middle (8-week-old) and old (6-month-old)-aged mice | HEPs from the H. erinaceus sporophore 0.5 or 1 g/bw/day by gavage for 28 days | Lachnospiraceae, Akkermansiaceae | Rikenellaceae, Bacteroidaceae | Anti-inflammatory activity and immunomodulatory activity. | [115] |
Acetic-acid-induced UC 11 adult rats | EP-1 12 0.6 and 1.2 g/kg by gavage for 11 days | SCFA producers | - | Antioxidant, anti-inflammatory, and immunoregulatory activities. Restoring a normal GM. | [116] |
DSS 13-induced UC C57BL/6 adult male mice | HEP10 14 50, 100, or 200 mg/kg by gavage for 7 days | Akkermansia muciniphila. | Proteobacteria | Restoring GM-alpha and -beta diversities. Anti-inflammatory activity in colons. | [117] |
IBD 15 adult rats and mice | HE/HEP3 100 mg/(kg * day) by gavage for 14 days | Anti-inflammatory bacteria, Corynebacterium, Bacteroides, Enterobacter, Acinetobacter, Desulfovibrio, Lactobacillus | Pro-inflammatory bacteria | Anti-inflammatory activity. Improving the GM composition. | [118,119] |
CTX 16-immunodeficient adult mice | HEP and FHEP 300 mg/kg/day by gavage for 21 days | Bacteriodetes, Firmicutes | Klebsiella and Shigella | Anti-inflammatory activity. Improving TJ 17 and MUC 18 expression. | [111] |
CTX-immunodeficient adult mice | HEPs 75, 150, and 300 mg/kg by gavage for 4 weeks | SCFA-producing bacteria, Alistipse, Muribaculaceae, Lachnospiraceae_NK4A136_group, Lachnospiracea, Ruminococcaceae, Ruminococcaceae_UCG-014 | Lactobacillus, Bacteroides, Alloprevotella | Improving the body weight and immune organ index. Increasing OTUs and adjusting GM-alpha and -beta diversities. | [121] |
Xenograft adult male Balb/C mice, implanting with 100,000 CT-26 wt cancer cells | HEP 100 mg/kg/day per os for 21 days | Probiotic bacteria: Bifidobacterium, Gemellales, Blautia, Sutterella, Anaerostipes, Roseburia, Lachnobacterium, Lactobacillus, and Desulfovibrio | Parabacteroides, Christensenellaceae, Anoxybacillus, Staphylococcus, Aggregatibacter, Comamonadaceae, Desulfovibrionaceae, Sporosarcina, Planococcaceae, Aerococcaceae, Flavobacteriaceae, and Bilophila | Reducing the 5-Fu-induced GM dysbiosis, suppressing tumor growth, and inhibiting inflammatory markers. | [120] |
Abbreviations: 1 H. erinaceus polysaccharides (HEPs), 2 shorty-chain fatty acid (SCFA), 3 H. erinaceus LGAM 4514 in 100% beech sawdust (HEBS), 4 H. erinaceus LGAM 4514 in olive pruning residues (HEOLRP), 5 gut microbiota (GM), 6 alkaline phosphatase (ALP), 7 low-density lipoprotein (LDL), 8 uric acid (UA), 9 creatinine (CREA), 10 body weight (Bw), 11 ulcerative colitis (UC), 12 purified unique polysaccharide isolated from H. erinaceus mycelium (EP-1), 13 dextran sulfate sodium (DSS), 14 low-weight polysaccharide from H. erinaceus with Mw: 9.9 kDa (HEP10), 15 intestinal bowel disease (IBD), 16 cyclophosphamide (CTX), 17 tight junctions (TJ), 18 mucin (MUC).